Module 10 - Pain Management - Overview and Assessment of Cancer Pain
Cancer associated pain can be characterized as either acute nociceptive pain (with or without inflammatory components) or as persistent pain associated with neoplastic disease. A subset of patients (~25%) experiences persistent pain as a consequence of antineoplastic treatment. Recognition of these syndromes can guide additional clinical assessment and treatment. In patients with active cancer, the management of persistent pain is an essential element in a comprehensive strategy of palliative care, which emphasizes multidimensional assessment and the coordinated use of treatments that mitigate suffering and provide support to the patient and family (see Module 12). The treatment principles applicable to persistent cancer pain also apply to other types of persistent pain associated with progressive, potentially life limiting disorders. Should you have technical questions, please contact the AMA Unified Service Center at 1-800-621-8335. Should you have questions regarding the content of this activity, please contact Barry Dickinson at firstname.lastname@example.org.
Type: Internet Activity (Enduring Material)
AMA PRA Category 1 Credit™
Certificate of Participation for Non-Physicians